EXICURE, INC. (XCUR) - Dilution Analysis

10-Q filing | 6.4M shares outstanding

10-K filing | 6.3M shares outstanding

10-Q filing | 6.3M shares outstanding

10-Q filing | 6.3M shares outstanding

S-1 filing: This S-1 filing outlines a resale of common stock by selling stockholders, who may sell their shares from time to time through various methods including brokerage transactions, underwriting, privately negotiated transactions, and open market sales.

10-Q filing | 6.2M shares outstanding

10-K filing | 6.3M shares outstanding

8-K filing: Exicure, Inc. sold 145,454 shares of common stock to Shin Chang Partners and RMS0718 Co., Ltd. at a price of $5.50 per share, resulting in gross proceeds of approximately $2 million. ($2.0M proceeds)

8-K filing: Exicure Inc. acquired all of the issued and outstanding equity securities of GPCR Therapeutics USA Inc. from GPCR Therapeutics Inc. for approximately $0.27 per share.

8-K filing: Exicure Inc. completed transactions to regain compliance with Nasdaq's minimum stockholders' equity requirement, including sales of common stock to HiTron Systems Inc. and SangSangIn Investment & Securities Co., Ltd., resulting in stockholders' equity of approximately $4.3 million. ($12.0M proceeds)

8-K filing: Exicure, Inc. entered into a Common Stock Purchase Agreement with SangSangIn Investment & Securities Co., Ltd. to issue and sell 433,332 shares of common stock at $4.61 per share, expecting gross proceeds of approximately $2 million. ($2.0M proceeds)

8-K filing: Exicure, Inc. entered into two common stock purchase agreements with HiTron Systems Inc. to issue and sell a total of 3,333,000 shares of common stock at a price of $3.00 per share. ($10.0M proceeds)

10-Q filing | 2.2M shares outstanding

8-K filing: The Company entered into debt-for-equity exchange agreements, issuing 237,233 shares to DGP Co., Ltd. and 101,991 shares to an individual promissory note holder, both at $3.00 per share.

8-K filing: Stock split 1-for-5 | Outstanding: 8,651,078 → 1,730,215

10-Q filing | 8.7M shares outstanding

10-Q filing | 8.7M shares outstanding

10-K filing | 8.0M shares outstanding

10-Q filing | 8.7M shares outstanding

10-Q filing | 8.4M shares outstanding

10-Q filing | 8.6M shares outstanding

10-K filing | 8.4M shares outstanding

10-Q filing | 5.0M shares outstanding

8-K filing: Exicure, Inc. entered into a Side Letter to Securities Purchase Agreement with CBI USA, Inc., confirming the issuance and sale of 3,400,000 shares of common stock at a price of $1.60 per share in a private placement. ($5.44M proceeds)

8-K filing: Exicure, Inc. entered into a securities purchase agreement with CBI USA, Inc. to issue and sell 3,400,000 shares of common stock at a price of $1.60 per share in a private placement, expected to close in the fourth quarter of 2022, with gross proceeds of approximately $5.4 million. ($5.4M proceeds)

10-Q filing | 4.5M shares outstanding

S-3 filing: This is an S-3 filing related to the resale of shares issued in a private placement that closed on May 18, 2022, where the company sold 867,369 shares of common stock at $5.81 per share, raising approximately $5.0 million.

8-K filing: Stock split 1-for-30 | Outstanding: 120,939,957 → 4,031,331

10-Q filing | 120.9M shares outstanding

8-K filing: Exicure, Inc. entered into a securities purchase agreement to issue and sell 26,021,111 shares of common stock at $0.1937 per share in a private placement, expecting to receive approximately $5.0 million in gross proceeds. ($5.0M proceeds)

10-K filing | 122.8M shares outstanding

8-K filing: Exicure, Inc. entered into a securities purchase agreement for a registered direct offering of shares of common stock, pre-funded warrants, and warrants, with gross proceeds expected to be approximately $11.5 million. ($11.5M proceeds)

10-Q filing | 88.1M shares outstanding

10-Q filing | 88.0M shares outstanding

10-Q filing | 87.9M shares outstanding

10-K filing | 88.0M shares outstanding

S-3 filing: Exicure, Inc. is offering shares of its common stock with an aggregate offering price of up to $50,000,000 through an "at the market offering".

10-Q filing | 87.2M shares outstanding

10-Q filing | 87.2M shares outstanding

POS AM filing: This is a POS AM filing to convert the Form S-1 into a registration statement on Form S-3, and contains an updated prospectus relating to the offering and sale of the shares of common stock that were registered for resale on the Form S-1.

POS AM filing: This is a post-effective amendment to convert the Form S-1 into a registration statement on Form S-3, and contains an updated prospectus relating to the offering and sale of 39,714,143 shares of common stock that were registered for resale on the Form S-1.

10-Q filing | 87.2M shares outstanding

10-K filing | 87.2M shares outstanding